title: Merck responds to PHARMAC's article on COX-2 inhibitors.
authors.forename: David
authors.initials: D
authors.lastname: Woolner
mesh_terms: D001168:Arthritis / Q000188:drug therapy*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D017277:Drug Approval; D004341:Drug Evaluation / Q000379:methods; D004345:Drug Industry; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration; D009520:New Zealand
chemical_list: D052246:Cyclooxygenase 2 Inhibitors